Results of the m-RESIST feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia

In the European Union between 0.2 and 2.6% of the population suffer from psychotic disorders, and around 40% can be considered resistant to pharmacological treatment [1]. Interventions based on m-Health solutions may be effective in increasing treatment adherence, relieving some of the symptoms of s...

Full description

Bibliographic Details
Main Authors: Eva Grasa, Anna Alonso-Solís, Katya Rubinstein, Asaf Caspi, Kinga Farkas, Zsolt Unoka, Susana Ochoa, Elena Huerta-Ramos, Jussi Seppälä, Erika Jääskeläinen, Cari Almazán, Johanna Caro Mendivelso, Anna Triantafillou, Panagiotis Kokkinakis, Shenja Van Der Graaf, Charlotte Jewell, Jesús Berdún, Elisenda Reixac, Iluminada Corripio
Format: Article
Language:English
Published: Ubiquity Press 2019-08-01
Series:International Journal of Integrated Care
Subjects:
Online Access:https://www.ijic.org/articles/4756